Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1993;88:416-429

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Volpi, A.
Right arrow Articles by Tognoni, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Volpi, A.
Right arrow Articles by Tognoni, G.

Circulation, Vol 88, 416-429, Copyright © 1993 by American Heart Association


ARTICLES

Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base

A Volpi, C De Vita, MG Franzosi, E Geraci, AP Maggioni, F Mauri, E Negri, E Santoro, L Tavazzi and G Tognoni
GISSI Coordinating Center, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

BACKGROUND. Current knowledge of risk assessment in survivors of myocardial infarction is largely based on data gathered before the advent of thrombolysis. It must be determined whether and to what extent available information and proposed criteria of prognostication are applicable in the thrombolytic era. METHODS AND RESULTS. We reassessed risk prediction in the 10,219 survivors of myocardial infarction with follow-up data available (ie, 98% of the total) who had been enrolled in the GISSI-2 trial, relying on a set of prespecified variables. The 3.5% 6-month all-cause mortality rate of these patients compared with the higher value of 4.6% found in the corresponding GISSI- 1 cohort, originally allocated to streptokinase therapy, indicates a 24% reduction in postdischarge 6-month mortality. On multivariate analysis (Cox model), the following variables were predictors of 6- month all-cause mortality: ineligibility for exercise test for both cardiac (relative risk [RR], 3.30; 95% confidence interval [CI], 2.36- 4.62) and noncardiac reasons (RR, 3.28; 95% CI, 2.23-4.72), early left ventricular failure (RR, 2.41; 95% CI, 1.87-3.09), echocardiographic evidence of recovery phase left ventricular dysfunction (RR, 2.30; 95% CI, 1.78-2.98), advanced (more than 70 years) age (RR, 1.81; 95% CI, 1.43-2.30), electrical instability (ie, frequent and/or complex ventricular arrhythmias) (RR, 1.70; 95% CI, 1.32-2.19), late left ventricular failure (RR, 1.54; 95% CI, 1.17-2.03), previous myocardial infarction (RR, 1.47; 95% CI, 1.14-1.89), and a history of treated hypertension (RR, 1.32; 95% CI, 1.05-1.65). Early post-myocardial infarction angina, a positive exercise test, female sex, history of angina, history of insulin-dependent diabetes, and anterior site of myocardial infarction were not risk predictors. On further multivariate analysis, performed on 8315 patients with the echocardiographic indicator of left ventricular dysfunction available, only previous myocardial infarction was not retained as an independent risk predictor. CONCLUSIONS. A decline in 6-month mortality of myocardial infarction survivors, seen within 6 hours of symptom onset, has been observed in recent years. Ineligibility for exercise test, early left ventricular failure, and recovery-phase left ventricular dysfunction are the most powerful (RR, > 2) predictors of 6-month mortality among patients recovering from myocardial infarction after thrombolysis. Qualitative variables reflecting residual myocardial ischemia do not appear to be risk predictors. The lack of an independent adverse influence of early post-myocardial infarction angina on 6-month survival represents a major difference between this study and those of the prethrombolytic era.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. B. Chicos, P. J. Kannankeril, A. H. Kadish, and J. J. Goldberger
Parasympathetic effects on cardiac electrophysiology during exercise and recovery in patients with left ventricular dysfunction
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H743 - H749.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. L. Nicolosi, S. Golcea, C. Ceconi, G. Parrinello, A. Decarli, M. Chiariello, W. J. Remme, L. Tavazzi, R. Ferrari, and on behalf of the PREAMI Investigators
Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study
Eur. Heart J., July 1, 2009; 30(13): 1656 - 1665.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Mizuno, S Fujimoto, Y Saito, and S Nakamura
Depressed recovery of subendocardial perfusion in persistent heart failure after complete revascularisation in diabetic patients with hibernating myocardium
Heart, May 1, 2009; 95(10): 830 - 834.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza
CHAPTER 17 Chronic Ischaemic Heart Disease
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ishii, T. Amano, T. Matsubara, and T. Murohara
Pharmacological Intervention for Prevention of Left Ventricular Remodeling and Improving Prognosis in Myocardial Infarction
Circulation, December 16, 2008; 118(25): 2710 - 2718.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. Kohler, J. C. T. Pepperell, B. Casadei, S. Craig, N. Crosthwaite, J. R. Stradling, and R. J. O. Davies
CPAP and measures of cardiovascular risk in males with OSAS
Eur. Respir. J., December 1, 2008; 32(6): 1488 - 1496.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1179 - 1199.
[Full Text] [PDF]


Home page
CirculationHome page
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
Circulation, September 30, 2008; 118(14): 1497 - 1518.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
T. W. Galema, M. L. Geleijnse, S.-C. Yap, R. T. van Domburg, E. Biagini, W. B. Vletter, and F. J. Ten Cate
Assessment of left ventricular ejection fraction after myocardial infarction using contrast echocardiography
Eur J Echocardiogr, March 1, 2008; 9(2): 250 - 254.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Dimmeler, J. Burchfield, and A. M. Zeiher
Cell-Based Therapy of Myocardial Infarction
Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 208 - 216.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
B. Blasko, R. Kolka, P. Thorbjornsdottir, S. T. Sigurtharson, G. Sigurthsson, Z. Ronai, M. Sasvari-Szekely, S. Bothvarsson, G. Thorgeirsson, Z. Prohaszka, et al.
Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction
Int. Immunol., January 1, 2008; 20(1): 31 - 37.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Jahangir, S. Sagar, and A. Terzic
Aging and cardioprotection
J Appl Physiol, December 1, 2007; 103(6): 2120 - 2128.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Radauceanu, F. Moulin, W. Djaballah, P. Y. Marie, F. Alla, B. Dousset, J. M. Virion, J. Capiaumont, G. Karcher, E. Aliot, et al.
Residual stress ischaemia is associated with blood markers of myocardial structural remodelling
Eur J Heart Fail, April 1, 2007; 9(4): 370 - 376.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. S. Jassal, T. G. Neilan, A. D. Pradhan, K. E. Lynch, G. Vlahakes, A. K. Agnihotri, and M. H. Picard
Surgical Management of Infective Endocarditis: Early Predictors of Short-Term Morbidity and Mortality
Ann. Thorac. Surg., August 1, 2006; 82(2): 524 - 529.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. F. Hernandez, E. J. Velazquez, S. D. Solomon, R. Kilaru, R. Diaz, C. M. O'Connor, G. Ertl, A. P. Maggioni, J.-L. Rouleau, W. van Gilst, et al.
Left Ventricular Assessment in Myocardial Infarction: The VALIANT Registry
Arch Intern Med, October 10, 2005; 165(18): 2162 - 2169.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Pascale, P. Taffe, C. Regamey, L. Kappenberger, and M. Fromer
Reduced Ejection Fraction After Myocardial Infarction: Is It Sufficient To Justify Implantation of a Defibrillator?
Chest, October 1, 2005; 128(4): 2626 - 2632.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Hoffmann, S. von Bardeleben, F. ten Cate, A. C. Borges, J. Kasprzak, C. Firschke, S. Lafitte, N. Al-Saadi, S. Kuntz-Hehner, M. Engelhardt, et al.
Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography
Eur. Heart J., March 2, 2005; 26(6): 607 - 616.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Desideri, P M Fioretti, L Cortigiani, G Trocino, C Astarita, D Gregori, J Bax, J Velasco, L Celegon, R Bigi, et al.
Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial
Heart, February 1, 2005; 91(2): 146 - 151.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Latini, A. P. Maggioni, G. Peri, L. Gonzini, D. Lucci, P. Mocarelli, L. Vago, F. Pasqualini, S. Signorini, D. Soldateschi, et al.
Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction
Circulation, October 19, 2004; 110(16): 2349 - 2354.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Carrabba, R. Valenti, G. Parodi, G. M. Santoro, and D. Antoniucci
Left Ventricular Remodeling and Heart Failure in Diabetic Patients Treated With Primary Angioplasty for Acute Myocardial Infarction
Circulation, October 5, 2004; 110(14): 1974 - 1979.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J E Udelson and E J Flint
Radionuclide imaging in risk assessment after acute coronary syndromes
Heart, August 1, 2004; 90(suppl_5): v16 - v25.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Fincke, J. S. Hochman, A. M. Lowe, V. Menon, J. N. Slater, J. G. Webb, T. H. LeJemtel, G. Cotter, and SHOCK Investigators
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry
J. Am. Coll. Cardiol., July 21, 2004; 44(2): 340 - 348.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
P. C. Austin, D. A. Alter, and J. V. Tu
The Use of Fixed-and Random-Effects Models for Classifying Hospitals as Mortality Outliers: A Monte Carlo Assessment
Med Decis Making, November 1, 2003; 23(6): 526 - 539.
[Abstract] [PDF]


Home page
Eur Heart JHome page
A. Desideri, P. M. Fioretti, L. Cortigiani, D. Gregori, C. Coletta, C. Vigna, F. Tota, R. Rambaldi, J. Bax, L. Celegon, et al.
Cost of strategies after myocardial infarction (COSTAMI): A multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction
Eur. Heart J., September 2, 2003; 24(18): 1630 - 1639.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
E. J. Velazquez, M. A. Pfeffer, J. V. McMurray, A. P. Maggioni, J.-L. Rouleau, F. Van de Werf, L. Kober, H. D. White, K. Swedberg, J. D. Leimberger, et al.
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context
Eur J Heart Fail, August 1, 2003; 5(4): 537 - 544.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Hasdai, E. I Lev, S. Behar, V. Boyko, N. Danchin, A. Vahanian, and A. Battler
Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: lessons from the Euro-Heart Survey of acute coronary syndromes
Eur. Heart J., April 1, 2003; 24(7): 623 - 629.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Picard, R. Davidoff, L. A. Sleeper, L. A. Mendes, C. R. Thompson, V. Dzavik, R. Steingart, K. Gin, H. D. White, J. S. Hochman, et al.
Echocardiographic Predictors of Survival and Response to Early Revascularization in Cardiogenic Shock
Circulation, January 21, 2003; 107(2): 279 - 284.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Nijland, O Kamp, P M J Verhorst, W G de Voogt, and C A Visser
Early prediction of improvement in ejection fraction after acute myocardial infarction using low dose dobutamine echocardiography
Heart, December 1, 2002; 88(6): 592 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
P Tyden, O Hansen, G Engstrom, B Hedblad, and L Janzon
Myocardial infarction in an urban population: worse long term prognosis for patients from less affluent residential areas
J Epidemiol Community Health, October 1, 2002; 56(10): 785 - 790.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.E. Otterstad, M.G. St. John Sutton, G.S. Froeland, I. Holme, T. Skjaerpe, and C. Hall
Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function
Eur. Heart J., July 1, 2002; 23(13): 1011 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. M. Richards, M. G. Nicholls, R. W. Troughton, J. G. Lainchbury, J. Elliott, C. Frampton, E. A. Espiner, I. G. Crozier, T. G. Yandle, and J. Turner
Antecedent hypertension and heart failure after myocardial infarction
J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1182 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
P. C. Austin
A Comparison of Bayesian Methods for Profiling Hospital Performance
Med Decis Making, April 1, 2002; 22(2): 163 - 172.
[Abstract] [PDF]


Home page
HeartHome page
P Andrassy, M Zielinska, R Busch, A Schomig, and C Firschke
Myocardial blood volume and the amount of viable myocardium early after mechanical reperfusion of acute myocardial infarction: prospective study using venous contrast echocardiography
Heart, April 1, 2002; 87(4): 350 - 355.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. E. Sheifer, T. A. Manolio, and B. J. Gersh
Unrecognized Myocardial Infarction
Ann Intern Med, November 6, 2001; 135(9): 801 - 811.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Simon and H. Rosolova
Predicting the coronary risk in primary and secondary prevention. What is the difference?
Eur. Heart J., November 2, 2001; 22(22): 2047 - 2049.
[PDF]


Home page
Eur Heart JHome page
R Marchioli, F Avanzini, F Barzi, C Chieffo, A Di Castelnuovo, M.G Franzosi, E Geraci, A.P Maggioni, R.M Marfisi, N Mininni, et al.
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart
Eur. Heart J., November 2, 2001; 22(22): 2085 - 2103.
[Abstract] [PDF]


Home page
ChestHome page
M. del Mar de la Torre, J. A. San Roman, J. Bermejo, G. Pastor, J. Alonso, and F. Fernandez-Aviles
Prognostic Power of Dobutamine Echocardiography After Uncomplicated Acute Myocardial Infarction in the Elderly
Chest, October 1, 2001; 120(4): 1200 - 1205.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S H Poulsen, S E Jensen, J E Moller, and K Egstrup
Prognostic value of left ventricular diastolic function and association with heart rate variability after a first acute myocardial infarction
Heart, October 1, 2001; 86(4): 376 - 380.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
J. C. Nicolau, C. V. Serrano Jr., S. A.C. Garzon, and J. A.F. Ramires
Prognosis of acute myocardial infarction in the thrombolytic era: medical evaluation is still valuable
Eur J Heart Fail, October 1, 2001; 3(5): 569 - 576.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G I W Galasko, S Basu, A Lahiri, and R Senior
A prospective comparison of echocardiographic wall motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction
Heart, September 1, 2001; 86(3): 271 - 276.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J Abdulla, B Brendorp, C Torp-Pedersen, L Kober, and on behalf of the TRACE study group
Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction?
Eur. Heart J., June 2, 2001; 22(12): 1008 - 1014.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
D. Scrutinio, C. Cimminiello, E. Marubini, M. Vittoria Pitzalis, M. Di Biase, P. Rizzon, and the STAMI Group
Ticlopidine versus aspirin after myocardial infarction (stami) trial
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1259 - 1265.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Bigi, A Desideri, A Galati, J J Bax, C Coletta, C Fiorentini, and P M Fioretti
Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction
Heart, April 1, 2001; 85(4): 417 - 423.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
G. Cerisano, L. Bolognese, P. Buonamici, R. Valenti, N. Carrabba, E. V. Dovellini, P. D. Pucci, G. M. Santoro, and D. Antoniucci
Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 793 - 799.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. Tavazzi
Towards a more precise definition of heart failure aetiology
Eur. Heart J., February 1, 2001; 22(3): 192 - 195.
[PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Takano, X.-L. Tang, E. Kodani, and R. Bolli
Late preconditioning enhances recovery of myocardial function after infarction in conscious rabbits
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2372 - H2381.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. A. Morrow, E. M. Antman, A. Charlesworth, R. Cairns, S. A. Murphy, J. A. de Lemos, R. P. Giugliano, C. H. McCabe, and E. Braunwald
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy
Circulation, October 24, 2000; 102(17): 2031 - 2037.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. Lindahl, H. Toss, A. Siegbahn, P. Venge, L. Wallentin, and The FRISC Study Group
Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease
N. Engl. J. Med., October 19, 2000; 343(16): 1139 - 1147.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S. C GREAVES
Assessment of left ventricular systolic function in research and in clinical practice
Heart, May 1, 2000; 83(5): 493 - 494.
[Full Text]


Home page
CirculationHome page
S. H. Poulsen, N. B. Host, S. E. Jensen, and K. Egstrup
Relationship Between Serum Amino-Terminal Propeptide of Type III Procollagen and Changes of Left Ventricular Function After Acute Myocardial Infarction
Circulation, April 4, 2000; 101(13): 1527 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.R. Conti
Determining prognosis early after a myocardial infarction
Eur. Heart J., April 2, 2000; 21(8): 609 - 610.
[PDF]


Home page
J Am Coll CardiolHome page
M. L. Chuang, M. G. Hibberd, C. J. Salton, R. A. Beaudin, M. F. Riley, R. A. Parker, P. S. Douglas, and W. J. Manning
Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: Assessment by two- and three-dimensional echocardiography and magnetic resonance imaging
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Kim, R. M. Judd, E.-L. Chen, D. S. Fieno, T. B. Parrish, and J. A. C. Lima
Relationship of Elevated 23Na Magnetic Resonance Image Intensity to Infarct Size After Acute Reperfused Myocardial Infarction
Circulation, July 13, 1999; 100(2): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. B. Ravn, U. Moeldrup, C. I. O. Brookes, L. B. Ilkjaer, P. White, M. Chew, L. Jensen, S. Johnsen, L. Birk-Soerensen, and V. E. Hjortdal
Intravenous Magnesium Reduces Infarct Size After Ischemia/Reperfusion Injury Combined with a Thrombogenic Lesion in the Left Anterior Descending Artery
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 569 - 574.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Picano, R. Sicari, P. Landi, L. Cortigiani, R. Bigi, C. Coletta, A. Galati, J. Heyman, R. Mattioli, M. Previtali, et al.
Prognostic Value of Myocardial Viability in Medically Treated Patients With Global Left Ventricular Dysfunction Early After an Acute Uncomplicated Myocardial Infarction : A Dobutamine Stress Echocardiographic Study
Circulation, September 15, 1998; 98(11): 1078 - 1084.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Previtali, R. Fetiveau, L. Lanzarini, C. Cavalotti, and C. Klersy
Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis
J. Am. Coll. Cardiol., August 1, 1998; 32(2): 380 - 386.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. Baigent, R. Collins, P. Appleby, S. Parish, P. Sleight, and R. Peto
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
BMJ, May 2, 1998; 316(7141): 1337 - 1343.
[Abstract] [Full Text]


Home page
CirculationHome page
K. C. Wu, E. A. Zerhouni, R. M. Judd, C. H. Lugo-Olivieri, L. A. Barouch, S. P. Schulman, R. S. Blumenthal, and J. A. C. Lima
Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction
Circulation, March 3, 1998; 97(8): 765 - 772.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. G. Goodman, A. Langer, A. M. Ross, N. M. Wildermann, A. Barbagelata, E. B. Sgarbossa, G. S. Wagner, C. B. Granger, R. M. Califf, E. J. Topol, et al.
Non–Q-Wave Versus Q-Wave Myocardial Infarction After Thrombolytic Therapy : Angiographic and Prognostic Insights From the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries–I Angiographic Substudy
Circulation, February 10, 1998; 97(5): 444 - 450.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Malacrida, M. Genoni, A. P. Maggioni, V. Spataro, S. Parish, A. Palmer, R. Collins, T. Moccetti, and The Third International Study of Infarct Survival
A Comparison of the Early Outcome of Acute Myocardial Infarction in Women and Men
N. Engl. J. Med., January 1, 1998; 338(1): 8 - 14.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Sim, K. M. McDonald, P. W. Lavori, C. M. Norbutas, and M. A. Hlatky
Quantitative Overview of Randomized Trials of Amiodarone to Prevent Sudden Cardiac Death
Circulation, November 4, 1997; 96(9): 2823 - 2829.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. W. Haider, L. Chen, M. G. Larson, J. C. Evans, M. H. Chen, and D. Levy
Antecedent Hypertension Confers Increased Risk for Adverse Outcomes After Initial Myocardial Infarction
Hypertension, November 1, 1997; 30(5): 1020 - 1024.
[Abstract] [Full Text]


Home page
CirculationHome page
L. Tavazzi and A. Volpi
Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) Trials
Circulation, March 4, 1997; 95(5): 1341 - 1345.
[Full Text]


Home page
Arch Intern MedHome page
R. S. Vasan and D. Levy
The Role of Hypertension in the Pathogenesis of Heart Failure: A Clinical Mechanistic Overview
Arch Intern Med, September 9, 1996; 156(16): 1789 - 1796.
[Abstract] [PDF]


Home page
CirculationHome page
G. Zuanetti, J. M.M. Neilson, R. Latini, E. Santoro, A. P. Maggioni, and D. J. Ewing
Prognostic Significance of Heart Rate Variability in Post–Myocardial Infarction Patients in the Fibrinolytic Era: The GISSI-2 Results
Circulation, August 1, 1996; 94(3): 432 - 436.
[Abstract] [Full Text]


Home page
CirculationHome page
K. L. Lee, L. H. Woodlief, E. J. Topol, W. D. Weaver, A. Betriu, J. Col, M. Simoons, P. Aylward, F. Van de Werf, and R. M. Califf
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction : Results From an International Trial of 41 021 Patients
Circulation, March 15, 1995; 91(6): 1659 - 1668.
[Abstract] [Full Text]